Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund ...
1 小时
来自MSNHEALTH CHECK: After an ‘extraordinary’ year, analysts reckon Telix has a lot more tiger ...Broking analysts have raised their valuation of Telix Pharmaceuticals shares after the company's bullish update. ... Read More The post HEALTH CHECK: After an ‘extraordinary’ year, analysts reckon ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果